Burling Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Burling Wealth Partners's AZN Position: Q3 2026 in Review
Burling Wealth Partners reduced its AstraZeneca (AZN) stake by 32% in Q3 2026, selling an estimated $661K and leaving 8,507 shares worth $1.37M. The position accounts for 0.19% of the portfolio, ranked #83.
Burling Wealth Partners first reported a position in AZN in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.9M in Q4 2024. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Burling Wealth Partners held 8,507 shares of AstraZeneca worth $1.37M as of Q3 2026.
- Burling Wealth Partners sold 3,969 AstraZeneca shares in Q3 2026, an estimated $661K.
- AstraZeneca made up 0.19% of Burling Wealth Partners's portfolio in Q3 2026, its #83 holding.
- Burling Wealth Partners first reported a position in AstraZeneca in Q4 2024 and has held it in 8 quarters since.
- Burling Wealth Partners's AstraZeneca position peaked at $3.9M in Q4 2024.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Burling Wealth Partners's 13F filing for Q3 2026, filed 9 Nov 2026.